| S2248 |
Silmitasertib (CX-4945) |
Silmitasertib (CX-4945) is a potent and selective inhibitor of CK2 (casein kinase 2) with IC50 of 1 nM in a cell-free assay, less potent to Flt3, Pim1 and CDK1 (inactive in cell-based assay). Silmitasertib induces autophagy and promotes apoptosis. Phase 1/2. |
Selective |
CK2, IC50: 1 nM |
| S0707 |
Silmitasertib (CX-4945) sodium salt |
Silmitasertib (CX-4945)?sodium salt is a potent, orally bioavailable and selective inhibitor of casein kinase 2 (CK2) with IC50 of 1 nM against CK2α and CK2α'. |
Selective |
CK2α, IC50: 1 nM; CK2α', IC50: 1 nM |
| S9850 |
(E/Z)-GO289 |
(E/Z)-GO289 potently and selectively inhibits casein kinase 2 (CK2) at an IC50 of 7 nM in vitro kinase assay.
|
Selective |
CK2, IC50: 7 nM |
| S5516 |
Ellagic Acid hydrate |
Ellagic acid is a potent inhibitor of protein kinase CK2 with IC50s of 0.04, 2.9 and 3.5 μM for CK2, Lyn and PKA respectively. It shows potent antioxidant, anti-mutagenic and antidepressant properties. |
Selective |
CK2, IC50: 0.04 μM |
| S1105 |
LY294002 |
LY294002 (SF 1101, NSC 697286) is the first synthetic molecule known to inhibit PI3Kα/δ/β with IC50 of 0.5 μM/0.57 μM/0.97 μM, respectively; more stable in solution than Wortmannin, and also blocks autophagosome formation. It not only binds to class I PI3Ks and other PI3K-related kinases, but also to novel targets seemingly unrelated to the PI3K family. LY294002 also inhibits CK2 with IC50 of 98 nM. LY294002 is a non-specific DNA-PKcs inhibitor and activates autoph |
Selective |
CK2, IC50: 98 nM |
| S6536 |
TTP 22 |
TTP22 is a casein kinase 2 (CK2) inhibitor with an IC50 value of 100 nM. It displays selectivity for CK2 over JNK3, ROCK1, and MET with no inhibitory effects towards these kinases at 10 μM. |
Selective |
CK2, IC50: 100 nM |
| S5265 |
TBB |
TBB (4,5,6,7-tetrabromobenzotriazole) is a selective cell-permeable CK2 inhibitor with IC50 values of 0.9 and 1.6 μM for rat liver and human recombinant CK2 respectively. |
Selective |
CK2, Ki: 0.4 μM |
| S0995 |
BioE-1115 |
BioE-1115 is a highly selective and potent dual inhibitor of PAS kinase (PASK) and casein kinase 2α (CK2α) with IC50 of ~4 nM and ~10 μM, respectively. |
Selective |
CK2α, IC50: 10 μM |